I especially liked the fact that they have patients. If they demonstrate efficacy as they escallate in a Phase 1 Trial, it should boost the price tremendously. Do you know the details of the trial, if it's in clinical trials, could you provide a link.

I intend to get in, missed on my initial offer as it was up so much Friday, I bid slightly above the price it was trading at, but not enough. I have an opening bid in place that's slightly below where it ended the day, but if I don't get it there, I do intend to get in.

Gary